Eganelisib: Phosphatidylinositol 3-kinase γ (PI3Kγ) inhibitor Treatment of triple-negative breast cancer

L. Bo, Y. K. Zhang, S. E. Reznik, Z. S. Chen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Eganelisib: Phosphatidylinositol 3-kinase γ (PI3Kγ) inhibitor Treatment of triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases